-
Shanghai pushes policies signaling city's long-term development outlook
2022-10-14
Supportive measures released by policymakers in Shanghai have sent a clear signal to the city's development and will help global enterprises build a long-term outlook on investment in the city.
-
Shanghai announces measures to stabilize foreign trade
2022-03-29
Shanghai city in East China recently issued a series of policy measures, which are designed to further stabilize its foreign trade.
-
New measures in place to draw capital to Shanghai
2022-01-20
A guideline to further facilitate investment in Shanghai was released by the municipal government on Tuesday, which experts said will help further stabilize the city's economic growth and improve its overall business environment.
-
New guideline to facilitate market entities in Shanghai
2022-01-17
The latest measures announced by the Shanghai municipal government on Thursday to activate the growth and development of market entities showed the metropolis' resolution to guarantee a fair play business environment for its more than 3 million market entities, experts said.
-
New policy makes bulk commodity transactions easier in Shanghai
2022-01-13
A total of 28,300 tons of copper has recently been transported to the C. Steinweg warehouse in the Waigaoqiao Port Comprehensive Bonded Area in the China (Shanghai) Pilot Free Trade Zone.
-
Highlights of major economic policies in 2022
2022-01-04
The People's Bank of China, China Banking Regulatory Commission, China Securities Regulatory Commission and other government bodies released their major tasks related to economic development for 2022 mapped out by the Central Economic Work Conference.
-
Cross-border trade in services gets fillip
2021-11-16
China has been proactively advancing the completion and release of a negative list for cross-border trade in services in the pilot free trade zones, the Ministry of Commerce said on Thursday.
-
Biomedicine sector to be expanded in Shanghai
2021-11-10
The Shanghai government will boost the growth of its biomedical industry during the 14th Five-Year Plan period (2021-25) in support of China's continued efforts toward high-quality development.